MEI Pharma, Inc. Quarterly Operating Income (Loss) in USD from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
MEI Pharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2010 to Q3 2024.
  • MEI Pharma, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$8.35M, a 115% decline year-over-year.
  • MEI Pharma, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$49.1M, a 234% decline year-over-year.
  • MEI Pharma, Inc. annual Operating Income (Loss) for 2024 was $14.5M.
  • MEI Pharma, Inc. annual Operating Income (Loss) for 2023 was -$36.8M, a 51.3% increase from 2022.
  • MEI Pharma, Inc. annual Operating Income (Loss) for 2022 was -$75.5M, a 24.9% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$49.1M -$8.35M -$63.6M -115% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $14.5M -$19M -$7.9M -71.3% Apr 1, 2024 Jun 30, 2024 10-K 2024-09-19
Q1 2024 $22.4M -$9.83M +$6.56M +40% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $15.9M -$11.9M -$20.9M -234% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-13
Q3 2023 $36.7M $55.3M +$73.5M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$36.8M -$11.1M +$5.12M +31.6% Apr 1, 2023 Jun 30, 2023 10-K 2024-09-19
Q1 2023 -$41.9M -$16.4M +$5.17M +24% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$47M $8.93M +$26.6M Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-13
Q3 2022 -$73.6M -$18.2M +$1.89M +9.38% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$75.5M -$16.2M -$722K -4.67% Apr 1, 2022 Jun 30, 2022 10-K 2023-09-26
Q1 2022 -$74.8M -$21.6M -$5.16M -31.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$69.6M -$17.6M -$1.85M -11.7% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-09
Q3 2021 -$67.7M -$20.1M -$7.32M -57.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$60.4M -$15.5M -$27M -235% Apr 1, 2021 Jun 30, 2021 10-K 2022-09-08
Q1 2021 -$33.5M -$16.4M -$3.95M -31.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q4 2020 -$29.5M -$15.8M -$3.66M -30.3% Oct 1, 2020 Dec 31, 2020 10-Q/A 2022-05-23
Q3 2020 -$25.9M -$12.8M -$159K -1.26% Jul 1, 2020 Sep 30, 2020 10-Q/A 2022-05-23
Q2 2020 -$25.7M $11.5M +$23.2M Apr 1, 2020 Jun 30, 2020 10-K 2022-09-08
Q1 2020 -$48.9M -$12.4M +$173K +1.37% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$49.1M -$12.1M -$261K -2.2% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-04
Q3 2019 -$48.8M -$12.6M -$2.59M -25.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$46.2M -$11.7M -$4.28M -57.2% Apr 1, 2019 Jun 30, 2019 10-K/A 2022-05-23
Q1 2019 -$42M -$12.6M -$6.56M -108% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$35.4M -$11.8M -$5.68M -92% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-06
Q3 2018 -$29.7M -$10M -$1.15M -12.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$28.6M -$7.47M -$3.04M -68.4% Apr 1, 2018 Jun 30, 2018 10-K 2020-09-09
Q1 2018 -$25.6M -$6.05M -$5.38M -804% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$20.2M -$6.17M -$18M -152% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-07
Q3 2017 -$2.18M -$8.89M -$4.56M -106% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $2.38M -$4.44M +$1.38M +23.8% Apr 1, 2017 Jun 30, 2017 10-K 2019-08-28
Q1 2017 $1M -$670K +$4.74M +87.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$3.74M $11.8M +$16.9M Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-08
Q3 2016 -$20.7M -$4.32M +$322K +6.93% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$21M -$5.82M -$133K -2.34% Apr 1, 2016 Jun 30, 2016 10-K 2018-08-30
Q1 2016 -$20.9M -$5.41M +$3.55M +39.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 -$24.4M -$5.13M +$3.99M +43.8% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-08
Q3 2015 -$28.4M -$4.65M +$4.36M +48.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$32.8M -$5.69M +$2.87M +33.6% Apr 1, 2015 Jun 30, 2015 10-K 2017-09-05
Q1 2015 -$35.6M -$8.96M -$1.55M -21% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 -$34.1M -$9.12M -$2.77M -43.6% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-05
Q3 2014 -$31.3M -$9.01M -$4.09M -83.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 -$27.2M -$8.56M -$5.33M -165% Apr 1, 2014 Jun 30, 2014 10-K 2016-09-06
Q1 2014 -$21.9M -$7.41M -$4.64M -168% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$17.3M -$6.35M -$3.59M -130% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-06
Q3 2013 -$13.7M -$4.91M -$2.45M -99.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 -$11.2M -$3.23M -$1.03M -46.7% Apr 1, 2013 Jun 30, 2013 10-K 2015-09-02
Q1 2013 -$10.2M -$2.77M -$467K -20.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 -$9.73M -$2.76M -$799K -40.8% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-11
Q3 2012 -$8.93M -$2.47M -$533K -27.6% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 -$8.39M -$2.2M -$1.02M -85.6% Apr 1, 2012 Jun 30, 2012 10-K 2014-09-09
Q1 2012 -$7.38M -$2.3M -$970K -72.9% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$6.41M -$1.96M +$146K +6.94% Oct 1, 2011 Dec 31, 2011 10-Q 2012-02-09
Q3 2011 -$6.55M -$1.93M -$103K -5.63% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 -$6.45M -$1.19M Apr 1, 2011 Jun 30, 2011 10-K 2012-09-18
Q1 2011 -$1.33M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q4 2010 -$2.1M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-09
Q3 2010 -$1.83M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.